1. Situation épidémiologique du mélanome cutané en France et impact en termes de prévention;Cherie-Challine;Bull Epidemiol Hebdo,2004
2. Survival rates of patients with metastatic malignant melanoma;Sandru;J Med Life,2014
3. Targeted therapy and immunotherapy in advanced melanoma: an evolving paradigm;Khattak;Ther Adv Med Oncol,2013
4. Transient MEK inhibitor-associated retinopathy in metastatic melanoma;Urner-Bloch;Ann Oncol,2014
5. Tolerability of BRAF/MEK inhibitor combinations: adverse event evaluation and management;Heinzerling;ESMO Open,2019